NCT04703686
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04703686
Title Treatment by a Bispecific CD3xCD20 Antibody for Relapse/Refractory Lymphomas After CAR T-cells Therapy
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors The Lymphoma Academic Research Organisation
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA

Facility Status City State Zip Country Details
CHU Amiens Picardie Site sud Amiens France Details
CHU de Clermont Ferrand Clermont-Ferrand 63000 France Details
Hopital Henri Mondor Créteil 94010 France Details
CHU de Dijon - Hôpital le Bocage Dijon 21034 France Details
CHU de Grenoble Grenoble 38043 France Details
CHRU Lille - Hôpital Claude Huriez Lille 59037 France Details
CHU Montpellier Montpellier 34295 France Details
CHU Nantes Nantes 44093 France Details
Hôpital Saint Louis Paris 75475 France Details
Hopital Necker enfants malades Paris 7574 France Details
APHP - Hôpital de la Pitiè Salpetrière Paris France Details
APHP - Hôpital Saint Antoine Paris France Details
CHU de Bordeaux - Hôpital Haut Leveque Pessac 33604 France Details
CHU Lyon Sud Pierre-Bénite 69130 France Details
CHU de Rennes - Hôpital Pontchaillou Rennes 35033 France Details
Centre Henri Becquerel Rouen 76038 France Details
IUCT Oncopole Toulouse 31059 France Details
CHU Tours Hopital Bretonneau Tours 37044 France Details
CHU de Brabois Vandœuvre-lès-Nancy France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field